Growth Factor News and Research

RSS

Gothenburg scientists discover possible new cancer treatment target

Researchers at the University of Gothenburg have identified a previously unknown mechanism controlling tumor growth in cultured cells and mice.

30 Aug 2022

High-throughput proteomics reveals pregnancy-specific responses to COVID-19

Researchers evaluated pregnancy-specific responses to SARS-CoV-2 infection.

29 Aug 2022

Chinese researchers identify a new molecular mechanism of NASH pathogenesis

Nonalcoholic steatohepatitis (NASH), characterized by liver steatosis, inflammation and injury, has emerged as one of major causes for end-stage liver disease like hepatocellular carcinoma. However, what drives its progression?

25 Aug 2022

High levels of stress hormones can stop bone growth in children

As we go through life, our health and wellbeing is impacted by a variety of factors that in turn affect our growth and development.

23 Aug 2022

CD98 identified as a key mediator of pro-fibrotic and acute inflammatory responses in the lung

Researchers investigated the role of the CD98 glycoprotein in inducing an inflammatory response to SARS-CoV-2 in patients of progressive fibrosis interstitial lung diseases, including the archetypal PFILD, idiopathic pulmonary fibrosis.

18 Aug 2022

Remdesivir activates urotensin II receptor and induces cardiomyocyte dysfunction

In newly released research, scientists assessed the cardiac effects of remdesivir.

12 Aug 2022

Researchers identify novel molecular pathway that suppresses the spread of glioblastoma

UT Southwestern researchers have identified a molecular pathway responsible for the spread of glioblastoma to surrounding tissue in the brain, as well as an existing drug that curbed tumor growth in animal models.

10 Aug 2022

Decoy ACE2 receptors broadly neutralize SARS-CoV-2 variants

Researchers review current developments in preclinical studies associated with recombinant ACE2 decoy receptors against coronaviruses.

31 Jul 2022

Proteomics profiling of COVID-19 patients identifies dysregulated proteins and pathways

Researchers assessed the impact of SARS-CoV-2 infection and severity on coronary and Alzheimer’s disease pathways.

29 Jul 2022

Cytokine-based cancer immunotherapy: current progress and future prospects

In this interview, News-Medical talks to Dr. Shuang Zhou about cytokine-base cancer immunotherapy, the current state of the field, and future prospects.

From Sino Biological Inc. 18 Jul 2022

Mosaic loss of Y chromosome increases risk for heart failure and cardiac fibrosis in men

Why a condition that frequently occurs in aging men, in which an increasing number of hematopoietic cells display a loss of the Y chromosome, is associated with increased risk of mortality and age-related diseases is now a little clearer, thanks to work in mice.

15 Jul 2022

Phase I clinical trial of new blocking antibody therapy shows promising results for the treatment of advanced medulloblastoma

Effective and safe treatments are needed for medulloblastoma - the most common type of cancerous brain tumor in children - especially for patients whose cancer has spread to the spinal cord.

14 Jul 2022

A stepped regimen of anti-VEFG drugs leads to good vision outcomes in diabetic macular edema

Clinical trial results from the DRCR Retina Network suggest that a specific step strategy, in which patients with diabetic macular edema start with a less expensive medicine and switch to a more expensive medicine if vision does not improve sufficiently, gives results similar to starting off with the higher-priced drug.

14 Jul 2022

Study reveals a new molecular perspective to the cause of Gaucher's disease

A study by researchers at Baylor College of Medicine, the Jan and Dan Duncan Neurological Research Institute at Texas Children's Hospital and collaborating institutions is the first to associate neuronal activity to the levels of sphingolipids, a type of fat, in brain cells.

13 Jul 2022

Experimental model reveals possible causes and treatments for long-COVID

In a recent study published in the journal Science Translational Medicine, researchers characterized long-term pulmonary consequences of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) mouse-adapted strain (MA10) infection in BALB/c laboratory mice.

11 Jul 2022

Growth Factor News and Research

Gothenburg scientists discover possible new cancer treatment target

High-throughput proteomics reveals pregnancy-specific responses to COVID-19

Chinese researchers identify a new molecular mechanism of NASH pathogenesis

High levels of stress hormones can stop bone growth in children

CD98 identified as a key mediator of pro-fibrotic and acute inflammatory responses in the lung

Remdesivir activates urotensin II receptor and induces cardiomyocyte dysfunction

Researchers identify novel molecular pathway that suppresses the spread of glioblastoma

Decoy ACE2 receptors broadly neutralize SARS-CoV-2 variants

Proteomics profiling of COVID-19 patients identifies dysregulated proteins and pathways

Cytokine-based cancer immunotherapy: current progress and future prospects

Mosaic loss of Y chromosome increases risk for heart failure and cardiac fibrosis in men

Phase I clinical trial of new blocking antibody therapy shows promising results for the treatment of advanced medulloblastoma

A stepped regimen of anti-VEFG drugs leads to good vision outcomes in diabetic macular edema

Study reveals a new molecular perspective to the cause of Gaucher's disease

Experimental model reveals possible causes and treatments for long-COVID

COVID-19 impairs the insulin/IGF signaling pathway

The role of myostatin in female fertility

MIT chemists discover how changes in a shape-shifting receptor trigger cell growth

New technique offers higher-precision scRNA-seq data than current technologies

Midgestation increase in leptin puts child and mother at risk of cardiovascular disease

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News